MENU
+Compare
OCUL
Stock ticker: NASDAQ
AS OF
Jan 17, 04:59 PM (EDT)
Price
$8.01
Change
-$0.04 (-0.50%)
Capitalization
1.26B

OCUL Ocular Therapeutix Forecast, Technical & Fundamental Analysis

a developer of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology

Industry Biotechnology
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for OCUL with price predictions
Jan 14, 2025

OCUL's Indicator enters downward trend

The Aroon Indicator for OCUL entered a downward trend on January 14, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 217 similar instances where the Aroon Indicator formed such a pattern. In of the 217 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 10, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on OCUL as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for OCUL turned negative on January 14, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OCUL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where OCUL advanced for three days, in of 257 cases, the price rose further within the following month. The odds of a continued upward trend are .

OCUL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.578) is normal, around the industry mean (15.339). P/E Ratio (0.000) is within average values for comparable stocks, (87.552). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.851). OCUL has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (18.083) is also within normal values, averaging (263.778).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. OCUL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OCUL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

OCUL is expected to report earnings to rise 14.05% to -25 cents per share on March 06

Ocular Therapeutix OCUL Stock Earnings Reports
Q4'24
Est.
$-0.25
Q3'24
Beat
by $0.02
Q2'24
Missed
by $0.04
Q1'24
Missed
by $0.31
Q4'23
Missed
by $0.05
The last earnings report on November 14 showed earnings per share of -21 cents, beating the estimate of -23 cents. With 519.76K shares outstanding, the current market capitalization sits at 1.26B.
A.I. Advisor
published General Information

General Information

a developer of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
15 Crosby Drive
Phone
+1 781 357-4000
Employees
267
Web
https://www.ocutx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

OCUL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with PLRX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCUL
1D Price
Change %
OCUL100%
-0.98%
PLRX - OCUL
46%
Loosely correlated
-8.16%
RCUS - OCUL
46%
Loosely correlated
-0.98%
EYPT - OCUL
44%
Loosely correlated
-5.46%
XENE - OCUL
42%
Loosely correlated
-1.27%
RXRX - OCUL
41%
Loosely correlated
-0.31%
More